MX2019009759A - Composiciones de peptido estables. - Google Patents

Composiciones de peptido estables.

Info

Publication number
MX2019009759A
MX2019009759A MX2019009759A MX2019009759A MX2019009759A MX 2019009759 A MX2019009759 A MX 2019009759A MX 2019009759 A MX2019009759 A MX 2019009759A MX 2019009759 A MX2019009759 A MX 2019009759A MX 2019009759 A MX2019009759 A MX 2019009759A
Authority
MX
Mexico
Prior art keywords
peptide compositions
stable peptide
stable
kits
buffering
Prior art date
Application number
MX2019009759A
Other languages
English (en)
Inventor
Gordon W Laurie
Marc G Odrich
Michelle Carpenter
Thomas R Gadek
Paul A Laskar
Original Assignee
Tearsolutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tearsolutions Inc filed Critical Tearsolutions Inc
Publication of MX2019009759A publication Critical patent/MX2019009759A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Abstract

Esta solicitud se refiere generalmente a composiciones de péptido estables y kits que comprenden bajos niveles de agentes reguladores y quelantes, y métodos para utilizar las mismas.
MX2019009759A 2017-02-21 2018-02-20 Composiciones de peptido estables. MX2019009759A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762461467P 2017-02-21 2017-02-21
US201762530565P 2017-07-10 2017-07-10
PCT/US2018/018775 WO2018156501A1 (en) 2017-02-21 2018-02-20 Stable peptide compositions

Publications (1)

Publication Number Publication Date
MX2019009759A true MX2019009759A (es) 2020-07-27

Family

ID=63252954

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009759A MX2019009759A (es) 2017-02-21 2018-02-20 Composiciones de peptido estables.

Country Status (11)

Country Link
US (2) US20190381136A1 (es)
EP (1) EP3585412A4 (es)
JP (2) JP7223712B2 (es)
KR (1) KR20190137788A (es)
CN (1) CN110461350A (es)
AU (3) AU2018225485B2 (es)
BR (1) BR112019017275A2 (es)
CA (1) CA3054290A1 (es)
MX (1) MX2019009759A (es)
RU (1) RU2019126279A (es)
WO (1) WO2018156501A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022537383A (ja) * 2019-06-19 2022-08-25 ティアソリューションズ・インコーポレイテッド 拘束ペプチド
US11891588B2 (en) 2019-07-31 2024-02-06 Ecolab Usa Inc. Personal protective equipment free delimer compositions o
CN113209273A (zh) * 2021-04-30 2021-08-06 江苏普莱医药生物技术有限公司 一种抗菌肽涂剂及其制备方法
WO2024006653A2 (en) * 2022-07-01 2024-01-04 Tearsolutions, Inc. Stable peptide compositions and methods of use thereof for treatment of moderate/severe dry eye-related ocular symptoms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070213270A1 (en) * 2004-06-16 2007-09-13 Costantino Henry R Peptide yy formulations having increased stability and resistance to microbial agents
CN1993118B (zh) * 2004-11-05 2010-06-16 千寿制药株式会社 促进眼内渗透性的水性滴眼剂
KR20080033939A (ko) * 2005-06-17 2008-04-17 리지너크스 바이오 파마소티컬스, 인코포레이티드 동결 건조된 형태이거나, 또는 동결 건조될 수 있는 형태인엘케이케이티이티 및/또는 엘케이케이티엔티 펩티드조성물들
JP5475640B2 (ja) 2008-03-19 2014-04-16 千寿製薬株式会社 ラクリチンの部分ペプチド
US20100311688A1 (en) * 2009-06-05 2010-12-09 Aciex Therapeutics, Inc. Ophthalmic formulations, methods of manufacture, and methods of using same
US8518412B2 (en) 2009-09-16 2013-08-27 Senju Pharmaceutical Co, Ltd. Partial peptide of lacritin
CA2821969A1 (en) * 2010-12-21 2012-06-28 Recopharma Ab Tear substitutes
EP3117210A4 (en) 2014-03-12 2017-11-01 University Of Virginia Patent Foundation Compositions and methods for treating eye infections and disease

Also Published As

Publication number Publication date
RU2019126279A (ru) 2021-03-23
AU2021221401B2 (en) 2023-11-09
JP2020508349A (ja) 2020-03-19
US20220305083A1 (en) 2022-09-29
AU2021221401A1 (en) 2021-09-09
AU2018225485B2 (en) 2021-05-27
EP3585412A1 (en) 2020-01-01
AU2024200748A1 (en) 2024-02-29
JP7223712B2 (ja) 2023-02-16
JP2023058566A (ja) 2023-04-25
RU2019126279A3 (es) 2021-06-02
US20190381136A1 (en) 2019-12-19
EP3585412A4 (en) 2020-12-09
KR20190137788A (ko) 2019-12-11
BR112019017275A2 (pt) 2020-05-12
WO2018156501A1 (en) 2018-08-30
CA3054290A1 (en) 2018-08-30
CN110461350A (zh) 2019-11-15
AU2018225485A1 (en) 2019-09-05

Similar Documents

Publication Publication Date Title
MX2021006154A (es) Degradadores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
MX2020006812A (es) Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
MX2021014441A (es) Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
MX2021014443A (es) Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
PH12019502279A1 (en) Cleaning compositions and uses thereof
MX2019012431A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
MX2019011496A (es) Composiciones de niraparib.
MX2018004683A (es) Composicion detergente que comprende variantes de amilasa y proteasa.
MX2020007799A (es) Inhibidores de cinasa no derrepresible de control de aminoacido general 2 (gcn2) y sus usos.
MX2022007576A (es) Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
WO2019020602A3 (en) LUMINOPHORE AND COMPOSITION
MX2021012216A (es) Degradadores de transductores de señal y activadores de transcripción (stat) y usos de los mismos.
MX2022000053A (es) Moduladores de interaccion de sestrina-gator2 y sus usos.
MX2020001793A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.
MX2019009759A (es) Composiciones de peptido estables.
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
PH12019501872A1 (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
MX2020010951A (es) Anticuerpos anti-hla-g y utilizacion de los mismos.
MX2020001885A (es) Formulaciones de daptomicina.
MX2020013630A (es) Analogos de rapamicina y usos de los mismos.
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
PH12018502233A1 (en) ErbB INHIBITORS AND USES THEREOF
MX2019010984A (es) Composiciones de sintecina y metodos de uso.
MX2019010643A (es) Formas y composiciones de un inhibidor de proteina cinasa 2 activada por la proteina cinasa activada por mitogeno (mk2).
MX2022007841A (es) Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos.